What is the usual price range for a box of baricitinib tablets?

Baricitinib(Baricitinib) has been officially launched in mainland China and has been included in the national medical insurance directory. It is suitable for the long-term treatment of moderately to severely active rheumatoid arthritis and other diseases. Although medical insurance coverage has reduced patients' actual medication burden, the market price before reimbursement is still high, which also makes some patients have concerns when choosing treatment options. Taking the domestic market as an example, the specifications of a box of baricitinib are usually 2 mg or 4 mg tablets, and the content is related to the course of treatment. If calculated as 30 or 28 tablets per box, the unreimbursed price of the original drug may be around 3,000 yuan. The specific price fluctuates slightly and needs to be judged based on hospital pharmacy pricing and local medical insurance payment policies.

Within the scope of medical insurance reimbursement, the deductible lines, reimbursement ratios and limits may be different in different regions. General patients can be reimbursed, but the actual out-of-pocket price after reimbursement still needs to be determined based on the situation of the individual medical insurance account. For patients who are not included in the overall plan or have not yet established a medical insurance relationship, the out-of-pocket price may still pose financial pressure. Therefore, some patients will choose to obtain lower-priced overseas generic drugs through legal channels as an alternative.

Currently, the more common generic versions on the market mainly come from countries such as Bangladesh, especially the generic version produced by well-known Bangladeshi pharmaceutical companies. The price in the international market is significantly lower than that of the original drug. Usually, a box of baricitinib generics is sold for about between 200 yuan and 300 yuan. The specific price is affected by exchange rate fluctuations, logistics costs and purchasing channels. It should be noted that although generic drugs may be close to the original drugs in terms of efficacy and ingredients, their legality, safety and drug quality still need to be carefully screened.

Overall, for patients taking long-term medication, it is crucial to obtain a stable, compliant, and reasonably priced source of medication. It is recommended that when choosing drugs, patients should give priority to hospital pharmacies or certified drug supply channels to avoid choosing products from informal channels due to the pursuit of low prices, which may affect the treatment effect or cause safety risks.

Reference materials:https://go.drugbank.com/drugs/DB11817